Patient care, perseverance, bold ideas key to cancer breakthroughs: Tang Prize laureates (opens original article in a new tab)

The 2026 Tang Prize laureates in Biopharmaceutical Science, Steven A. Rosenberg, Michel Sadelain, and Carl H. June, were recognized for developing TIL and CAR-T therapies that use patients' immune cells to fight cancer, marking significant advancements in cancer treatment.

• The 2026 Tang Prize laureates in Biopharmaceutical Science are Steven A. Rosenberg, Michel Sadelain, and Carl H. June for their work on TIL and CAR-T therapies.
• Their research involved using patients' immune cells to fight cancer, leading to significant advancements in treating blood cancers and solid tumors.
• The laureates emphasized perseverance, unconventional thinking, and patient-centered approaches in their breakthroughs.